RG
PTCT icon

Rathbones Group’s PTC Therapeutics PTCT Stock Holding History

Rathbones Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Hold
23,500
– – 0.01% 305
2026
Q1 		$1.6M Hold
23,500
– – 0.01% 317
2025
Q4 		$1.79M Hold
23,500
– – 0.01% 306
2025
Q3 		$1.44M Hold
23,500
– – 0.01% 320
2025
Q2 		$1.15M Hold
23,500
– – 0.01% 330
2025
Q1 		$1.2M Hold
23,500
– – 0.01% 319
2024
Q4 		$1.06M Hold
23,500
– – 0.01% 331
2024
Q3 		$872K Sell
23,500
-235
-1% -$7.87K ﹤0.01% 343
2024
Q2 		$726K Hold
23,735
– – ﹤0.01% 361
2024
Q1 		$690K Hold
23,735
– – ﹤0.01% 371
2023
Q4 		$654K Hold
23,735
– – ﹤0.01% 360
2023
Q3 		$532K Buy
+23,735
New +$883K ﹤0.01% 390

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Rathbones Group's PTCT Position: Q2 2026 in Review

Rathbones Group held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 23,500 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #305.

Rathbones Group first reported a position in PTCT in Q3 2023 and has held it in 12 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Rathbones Group held 23,500 shares of PTC Therapeutics worth $1.92M as of Q2 2026.
  • Rathbones Group left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up 0.01% of Rathbones Group's portfolio in Q2 2026, its #305 holding.
  • Rathbones Group first reported a position in PTC Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.